Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» camidanlumab tesirine
camidanlumab tesirine
EHA: ADC preps filings for Hodgkin lymphoma drug after ph2 readout
Pharmaforum
Mon, 06/13/22 - 10:46 am
ADC Therapeutics
antibody-drug conjugate
camidanlumab tesirine
EMA
relapsed or refractory Hodgkins lymphoma
ADC Therapeutics sells off royalty share for lead antibody-drug conjugate in $325M deal
Endpoints
Thu, 08/26/21 - 10:53 am
ADC Therapeutics
Zynlonta
Cami
camidanlumab tesirine